A physiological model for the estimation of the fraction dose absorbed in humans

Journal of Medicinal Chemistry

Volumn 47, Issue 16, 2004, Pages 4022-4031

  Willmann, Stefan ^a   Schmitt, Walter ^a   Keldenich, Jörg ^b   Lippert, Jörg ^a   Dressman, Jennifer B ^c  

^a BAYER AG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DRUG ABSORPTION; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; STOMACH ABSORPTION; STOMACH EMPTYING; THEORETICAL MODEL;

ALGORITHMS; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLUBILITY;

EID: 3242778534     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030999b     Document Type: Article

References (55)

1. Levine, R. R. Factors affecting gastrointestinal absorption of drugs. Am. J. Dig. Dis. 1970, 15, 171-88.
2. Parsons, R. L. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes. Clin. Pharmacokinet. 1977, 2, 45-60.
3. DeYoung, J. L.; Tan, H. G.; Huber, H. E.; Zoglio, M. A. Effect of ionization on absorption of cephalosporins. J. Pharm. Sci. 1978, 67, 320-323.
4. Charman, W. N.; Porter, C. J.; Mithani, S.; Dressman, J. B. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 1997, 86, 269-282.
5. Nimmo, W. S. Drugs, diseases and altered gastric emptying. Clin. Pharmacokinet. 1976, 1, 189-203.
6. Beaugerie, L.; Lemann, M.; Jian, R.; Flourie, B.; Rain, J. D.; Rambaud, J. C. Effect of glucose and lipids on intestinal absorption of sorbitol: role of gastric emptying. Neurogastroenterol. Motil. 1996, 8, 235-239.
7. Yu, L. X. An Integrated Model for Determining Causes of Poor Oral Drug Absorption. Pharm. Res. 1999, 16, 1883-1887.
8. Marathe, P. H.; Wen, Y.; Norton, J.; Greene, D. S.; Barbhaiya, R. H.; Wilding, I. R. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br. J. Clin. Pharmacol. 2000, 50, 325-332.
9. Kimura, T.; Higaki, K. Gastrointestinal transit and drug absorption. Biol. Pharm. Bull. 2002, 25, 149-164.
10. Gibaldi, M. Gastrointestinal absorption - Physicochemical considerations. In Biopharmaceutics and Clinical Pharmacokinetics; Lea and Febiger: Philadelphia, 1991; pp 40-60.
11. Pade, V.; Stavchansky, S. Link between Drug Absorption Solubility and Permeability Measurements in Caco-2 Cells. J. Pharm. Sci. 1998, 87, 1604-1607.
12. Leahy, D. E.; Lynch, J.; Taylor, D. C. Mechanisms of absorption of small molecules. In Novel Drug Delivery and Its Therapeutic Application; Prescott, F. F., Nimmo, W. S., Eds.; John Wiley & Sons: New York, 1989; pp 33-44.
13. Camenisch, G.; Alsenz, J.; van de Waterbeemd, H.; Folkers, G. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 1998, 6, 317-324.
14. Camenisch, G.; Folkers, G.; van de Waterbeemd, H. Shapes of membrane permeability-lipophilicity curves: Extension of theoretical models with an aqueous pore pathway. Eur. J. Pharm. Sci. 1998, 6, 325-333.
15. Grass, G. M. Simulation models to predict oral drug absorption from in vitro data. Adv. Drug. Delivery Rev. 1997, 23, 199-219.
16. Poulin, P.; Theil, F. P. A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically based pharmacokinetic models in drug discovery. J. Pharm. Sci. 2000, 89, 16-35.
17. Norris, D. A.; Leesman, G. D.; Sinko, P. J.; Grass, G. M. Development of predictive pharmacokinetic simulation models for drug discovery. J. Controlled Release 2000, 65, 55-62.
18. Agoram, B.; Woltosz, W. S.; Bolger, M. B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. Drug Delivery Rev. 2001, 50, 41-67.
19. Lave, T.; Luttringer, O.; Zuegge, J.; Schneider, G.; Coassolo, P.; Theil, F. P. Prediction of human pharmacokinetics based on preclinical in vitro and in vivo data. Ernst Schering Res. Found. Workshop 2002, 37, 81-104.
20. Willmann, S.; Schmitt, W.; Keldenich, J.; Dressman, J. B. A physiological model for simulating gastro-intestinal flow and drug absorption in rats. Pharm. Res. 2003, 20, 1766-1771.
21. International Commission on Radiological Protection. Task Group on Reference Man: Report of the Task Group on Reference Man; Pergamon Press: Oxford, New York, 1992.
22. Dressman, J. B.; Berardi, R. R.; Dermentzoglou, L. C.; Russell, T. L.; Schmaltz, S. P.; Barnett, J. L.; Jarvenpaa, K. M. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm. Res. 1990, 7, 756-761.
23. Gray, V. A.; Dressman, J. B. Change of pH requirements for simulated intestinal fluid. Pharmacopeial Forum 1996, 22, 1943-1945.
24. Brener, W.; Hendrix, T. R.; McHugh, P. R. Regulation of the gastric emptying of glucose. Gastroenterology 1983, 85, 76-82.
25. Lin, H. C.; Doty, J. E.; Reedy, T. J.; Meyer, J. H. Inhibition of gastric emptying by acids depends on pH, titratable acidity, and length of intestine exposed to acid. Am. J. Physiol. 1990, 259, 1025-1030.
26. Davis, S. S.; Hardy, J. G.; Fara, J. W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986, 27, 886-892.
27. Malagelada, J. R.; Robertson, J. S.; Brown, M. L.; Remington, M.; Duenes, J. A.; Thomforde, G. M.; Carryer, P. W. Intestinal transit of solid and liquid components of a meal in health. Gastroenterology 1984, 87, 1255-1263.
28. Cummings, J. H. Absorption and secretion by the colon. Gut 1975, 16, 323-329.
29. Ashford, M.; Fell, J. T. Targeting drugs to the colon: delivery systems for oral administration. J. Drug. Target. 1994, 2, 241-257.
30. Rubinstein, A. Approaches and opportunities in colon-specific drug delivery. Crit. Rev. Ther. Drug. Carrier Syst. 1995, 12, 101-149.
31. Plusquellec, Y.; Efthymiopoulos, C.; Duthil, P.; Houin, G. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption. Med. Eng. Phys. 1999, 21, 525-532.
32. Yu, L. X.; Amidon, G. L. A compartmental absorption and transit model for estimating oral drug absorption. Int. J. Pharm. 1999, 186, 119-125.
33. Winne, D. Shift of pH-Absorption Curves. J. Pharmacokin. Biopharm. 1977, 5, 53-94.
34. Palm, K.; Stenberg, P.; Luthman, K.; Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 1997, 14, 568-571.
35. Wessel, M. D.; Jurs, P. C.; Tolan, J. W.; Muskal, S. M. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
36. Kansy, M.; Senner, F.; Gubernator, K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 1998, 41, 1007-1010.
37. Balon, K.; Riebesehl, B. U.; Muller, B. W. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res. 1999, 16, 882-888.
38. Bircher, J.; Sommer, W. Klinisch-pharmakologische Datensammlung; Wissenschaftl. Verl.-Ges.: Stuttgart, 1999.
39. Food and Drug Administration. Guidance for Industry - Dissolution Testing of Immediate Release Solid Oral Dosage Forms; U.S. Department of Health and Human Services: Rockville, MD, 1997.
40. Curatolo, W. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. Pharm. Sci. Technol. Today 1998, 1, 387-393.
41. Hidalgo, I. J.; Raub, T. J.; Borchardt, R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96, 736-749.
42. Hilgers, A. R.; Conradi, R. A.; Burton, P. S. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 1990, 7, 902-910.
43. Egan, W. J.; Merz, K. M.; Baldwin, J. J. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 2000, 43, 3867-3877.
44. Artursson, P.; Palm, K.; Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 2001, 46, 27-43.
45. Loidl-Stahlhofen, A.; Eckert, A.; Hartmann, T.; Schottner, M. Solid-supported lipid membranes as a tool for determination of membrane affinity: high-throughput screening of a physicochemical parameter. J. Pharm. Sci. 2001, 90, 599-606.
46. Loidl-Stahlhofen, A.; Hartmann, T.; Schottner, M.; Rohring, C.; Brodowsky, H.; Schmitt, J.; Keldenich, J. Multilamellar liposomes and solid-supported lipid membranes (TRANSIL): screening of lipid-water partitioning toward a high-throughput scale. Pharm. Res. 2001, 18, 1782-1788.
47. Walter, E.; Kissel, T.; Amidon, G. L. The intestinal peptide carrier: A potential transport system for small peptide derived drugs. Adv. Drug Delivery Rev. 1996, 20, 33-58.
48. van Asperen, J.; van Tellingen, O.; Tijssen, F.; Schinkel, A. H.; Beijnen, J. H. Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein. Br. J. Cancer 1999, 79, 108-113.
49. Collett, A.; Higgs, N. B.; Sims, E.; Rowland, M.; Warhurst, G. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. J. Pharmacol. Exp. Ther. 1999, 288, 171-178.
50. Liang, E.; Proudfoot, J.; Yazdanian, M. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm. Res. 2000, 17, 1168-1174.
51. Hastie, T.; Tibshirani, R.; Friedman, J. The Elements of Statistical Learning, Springer Series in Statistics; Springer-Verlag: Heidelberg, 2001; pp 193-224.
52. Langenbucher, F. Linearization of dissolution rate curves by the Inert monolithic device with a central hole for constant drug release Weibull distribution. J. Pharm. Pharmacol. 1972, 24, 979-981.
53. http://www.lionbioscience.com/solutions/products/idea.
54. http://www.simulations-plus.com/products/gastro_plus.html.
55. Parrott, N.; Lave, T. Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. Eur. J. Pharm. Sci. 2002, 17, 51-61.